A

A Rich History of Research at Massachusetts General Hospital

Here’s a blast from the past. An undated photo from one of the research labs at Massachusetts General Hospital. Mass General operates the largest hospital-based research program in the United States, and has been leading the way in medical innovation for more than 200 years. Do you have a guess for when this photo was ...

S

Study Suggests that Meditation and Yoga May Help Symptoms of IBS and IBD

A new pilot study that includes researchers from Massachusetts General Hospital, suggests that teaching relaxation techniques to patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) may help to alleviate their symptoms and better equip them to deal with the discomfort that results from both disorders. In a study of 48 individuals with IBS or IBD, entering ...

R

Researchers find possible link between microbiome population changes and onset of Type 1 diabetes

A coalition of researchers led by Dr. Ramnik Xavier of Mass General has identified a connection between changes in gut microbiota (the microbes living in our intestines) and the onset of Type 1 diabetes (T1D). The study, which followed infants who were genetically predisposed to develop T1D, found that the onset of diabetes was preceded by a drop in ...

M

Mass General Study Shows How Meditating Changes Brain Structure

Could meditating for 30 minutes a day actually change your brain structure? Sara Lazar, PhD, a neuroscientist at Mass General, has compiled brain imaging data suggesting that it can. In a controlled study of two groups of people who had never meditated before, Dr. Lazar found significant growth in brain volume in the group that ...

D

Does Gout Play a Role in Preventing Alzheimer’s Disease?

Could gout—a painful form of inflammatory arthritis—play a role in preventing Alzheimer’s disease? In a large study in the United Kingdom, Mass General researchers found that patients who previously had gout had a 24% lower risk of ‪#‎Alzheimers‬ disease. Gout is caused by high levels of uric acid in the blood, which can cause complications ...

L

Looking for Signs of Alzheimer’s Disease Before it Strikes

By working with a genetically linked group of 5,000 individuals in Colombia who have a significantly higher predisposition to early-onset ‪#‎Alzheimer‬’s disease than any other population in the world, Mass General researcher Yakeel T. Quiroz, PhD (pictured here), is hoping to better understand the subtle changes in the brain that take place prior to an ...

T

Tanzi Named to Time’s Top 100 Most Influential People

Massachusetts General Hospital’s Dr. Rudolph Tanzi was recognized on TIME Magazine’s list of 100 Most Influential People for his pioneering work in Alzheimer’s research. In writing about him, Maria Shriver noted that Dr. Tanzi is “one of the few scientists who has committed his career to finding a cure for Alzheimer’s, and last year he ...

T

This is What Tasting Looks Like

Dr. Seok-Hyun (Andy) Yun from the Wellman Center of Photomedicine at Massachusetts General Hospital was part of a global team of researchers that was able to observe live taste buds in action for the first time using a specially designed microscope system operated by Dr. Yun and his laboratory team. The study revealed that rather ...

M

MGH/MIT Study Identifies Neurons Important for Inductions of Natural REM Sleep

A joint research team from Mass General and Massachusetts Institute of Technology (MIT) may be one step closer to understanding the science of sleep. Using a scanning method that can activate light-sensitive proteins, the researchers found that the activation of cholinergic neurons (those that release the neurotransmitter acetylcholine) in two structures of the brain stem are key to inducing REM ...

A

A New Way to Screen for Cancer That’s as Easy as Swallowing a Pill

Researchers at Massachusetts General Hospital have developed an innovative new way to capture microscopic images of the esophagus using a capsule-sized, light-based imaging tool. This new method, which is currently being tested in clinical trials, could make it possible to screen millions of patients for precursors to esophageal cancer at a fraction of the current cost.